This Week Last Year in Medtech: Jan. 1-7This Week Last Year in Medtech: Jan. 1-7
See what Abbott, Medtronic, and Boston Scientific were up to this time last year.
Quidel's Diagnostic Success Pays Off with Major M&A
Quidel has entered into an agreement to acquire Ortho Clinical Diagnostics Holdings for $6 billion.
Hospital Staffing Shortages and Omicron Disrupt Elective Surgery
Rising COVID hospitalizations and hospital staffing shortages are once again expected to force elective procedures to the back burner.
Reducing Maternal and Newborn Deaths in Kenya through Medtech
Proximie’s platform will enable surgeons to 'virtually transport' into any operating room in the world to visually interact with and guide surgeons.
Tackling Tuberculosis in Children through Non-Invasive Sampling
42 Technology partnered with FIND and Rutgers University to develop a solution for diagnosing tuberculosis in children.
2 Medtech Giants Are Working to Enhance Cardiac Care in Southeast Asia
Boston Scientific and GE Healthcare are bringing their interventional cardiology portfolios to cardiac care centers.
Life After Tiara: Neovasc Rebounds with Progress on Reducer
Neovasc enrolled the first patient in a pivotal trial of a device that reduces angina symptoms in patients with refractory angina.
Emerging Markets Are a Missed Opportunity for Medical Device OEMs
An industry thought leader says medical device manufacturers often fail to fully realize commercial opportunities in emerging markets.
Abbott Unveils New Biowearables Category During Historic CES Keynote
Abbott's new consumer biowearables technology will track key biomarkers in the body such as glucose, ketones, lactate, and alcohol, to help consumers better understand their health and wellness.
Medtronic Recalls Synergy Cranial and Related Software Due to Glitch
Medtronic is recalling its Synergy Cranial and StealthStation S7 Cranial software due to the risk of potential inaccuracies.
About the Author
You May Also Like